Incyte to Report Second Quarter Financial Results
Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its second quarter 2016 financial results conference
call and webcast for 10:00 a.m. ET on Tuesday, August 9, 2016.
The schedule for the press release and conference call/webcast is as follows:
| |
|
|
|
|
|
|
|
|
•
|
|
Q2 2016 Press Release: |
|
|
|
August 9, 2016 at 7:00 a.m. ET |
|
•
|
|
Q2 2016 Conference Call: |
|
|
|
August 9, 2016 at 10:00 a.m. ET |
|
•
|
|
Domestic Dial-In Number: |
|
|
|
877-407-9221 |
|
•
|
|
International Dial-In Number: |
|
|
|
201-689-8597 |
|
•
|
|
Conference ID Number: |
|
|
|
13641107 |
|
|
|
|
|
|
|
|
If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number
for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will
need the conference ID number 13641107.
The live webcast with slides can be accessed at www.incyte.com under Investor Relations, Events and Webcasts and will be available for replay for 30 days.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and
commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's web site at
www.incyte.com.
Follow @Incyte on Twitter at https://twitter.com/Incyte.
Incyte Corporation
Investors
Michael Booth, DPhil, +1 302 498 5914
mbooth@incyte.com
or
Media
Catalina Loveman, +1 302 498 6171
cloveman@incyte.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160714005032/en/